Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

195 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Why do people stop treating contaminated drinking water with Solar Water Disinfection (SODIS)?
Tamas A, Mosler HJ. Tamas A, et al. Health Educ Behav. 2011 Aug;38(4):357-66. doi: 10.1177/1090198110374702. Epub 2011 Jan 28. Health Educ Behav. 2011. PMID: 21278305
Solar Water Disinfection (SODIS) is a simple method designed to treat microbiologically contaminated drinking water at household level. ...A low-value and a high-value relapser subtype as well as a low-value and a high-value continuer subtype we …
Solar Water Disinfection (SODIS) is a simple method designed to treat microbiologically contaminated drinking water at household leve …
Promotion of solar water disinfection: comparing the effectiveness of different strategies in a longitudinal field study in Bolivia.
Tamas A, Tobias R, Mosler HJ. Tamas A, et al. Health Commun. 2009 Dec;24(8):711-22. doi: 10.1080/10410230903264022. Health Commun. 2009. PMID: 20183380
Solar water disinfection (SODIS) is a simple method designed to treat microbiologically contaminated drinking water at the household level. ...In a longitudinal field study, we compared 2 interpersonal strategies (promoters and opinion leaders) and a centrali …
Solar water disinfection (SODIS) is a simple method designed to treat microbiologically contaminated drinking water at the household …
Protective effects of PACAP in excitotoxic striatal lesion.
Tamás A, Lubics A, Lengvári I, Reglódi D. Tamás A, et al. Ann N Y Acad Sci. 2006 Jul;1070:570-4. doi: 10.1196/annals.1317.083. Ann N Y Acad Sci. 2006. PMID: 16888227
The present article investigated the effects of pituitary adenylate cyclase-activating polypeptide (PACAP) treatment in a quinolinic acid (QA)-induced unilateral lesion of the striatum, a model of Huntington;s disease (HD). ...Three weeks after the treatment, a
The present article investigated the effects of pituitary adenylate cyclase-activating polypeptide (PACAP) treatment in a quinolinic …
Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
Tamás A, Lubics A, Szalontay L, Lengvári I, Reglodi D. Tamás A, et al. Behav Brain Res. 2005 Mar 30;158(2):221-9. doi: 10.1016/j.bbr.2004.09.002. Behav Brain Res. 2005. PMID: 15698888
The aim of the present study was to give a detailed comparative behavioral analysis of young and aging male and female rats following 6-hydroxydopamine (6-OHDA) lesion of the substantia nigra. ...It was found that both young and aging male animals were more susceptible to …
The aim of the present study was to give a detailed comparative behavioral analysis of young and aging male and female rats following …
PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.
Brown D, Tamas A, Reglodi D, Tizabi Y. Brown D, et al. Neurotox Res. 2014 Oct;26(3):230-9. doi: 10.1007/s12640-014-9468-x. Epub 2014 Apr 17. Neurotox Res. 2014. PMID: 24740430
There has been a growing recognition of the role of neuroinflammation caused by microglia-exaggerated release of inflammatory mediators in the pathogenesis of Parkinson's disease (PD). ...Such treatment resulted in approximately 54 % cell death as well as a reductio …
There has been a growing recognition of the role of neuroinflammation caused by microglia-exaggerated release of inflammatory mediato …
Pituitary adenylate cyclase activating polypeptide plays a role in olfactory memory formation in chicken.
Józsa R, Hollósy T, Tamás A, Tóth G, Lengvári I, Reglodi D. Józsa R, et al. Peptides. 2005 Nov;26(11):2344-50. doi: 10.1016/j.peptides.2005.03.054. Epub 2005 May 31. Peptides. 2005. PMID: 15927304
The aim of the present study was to investigate the function of PACAP in chicken embryonic olfactory memory formation by blocking PACAP at a sensitive period in ovo. ...Control eggs were treated only with saline, while other eggs received a single injection of the P …
The aim of the present study was to investigate the function of PACAP in chicken embryonic olfactory memory formation by blocking PACAP at …
Distribution of PACAP-38 in the central nervous system of various species determined by a novel radioimmunoassay.
Jakab B, Reglodi D, Józsa R, Hollósy T, Tamás A, Lubics A, Lengvári I, Oroszi G, Szilvássy Z, Szolcsányi J, Németh J. Jakab B, et al. J Biochem Biophys Methods. 2004 Oct 29;61(1-2):189-98. doi: 10.1016/j.jbbm.2004.03.002. J Biochem Biophys Methods. 2004. PMID: 15560935
Soon after the isolation and chemical characterization of PACAP, the first radioimmunoassay (RIA) methods have been developed, but it is a still rarely used laboratory technique in the field of PACAP research. The aim of the present study was to develop a novel, hig …
Soon after the isolation and chemical characterization of PACAP, the first radioimmunoassay (RIA) methods have been developed, but it is …
Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
Reglodi D, Tamás A, Lubics A, Szalontay L, Lengvári I. Reglodi D, et al. Regul Pept. 2004 Dec 15;123(1-3):85-94. doi: 10.1016/j.regpep.2004.05.016. Regul Pept. 2004. PMID: 15518897
In the present study, we investigated the effects of different doses of PACAP on the functional and morphological outcome in a rat model of Parkinson's disease. ...These results indicate that PACAP may be a promising therapeutic agent in Parkinson's disease....
In the present study, we investigated the effects of different doses of PACAP on the functional and morphological outcome in a rat mo …
Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.
Farkas O, Tamás A, Zsombok A, Reglodi D, Pál J, Büki A, Lengvári I, Povlishock JT, Dóczi T. Farkas O, et al. Regul Pept. 2004 Dec 15;123(1-3):69-75. doi: 10.1016/j.regpep.2004.05.014. Regul Pept. 2004. PMID: 15518895
Pituitary adenylate cyclase activating polypeptide (PACAP) is a widely distributed neuropeptide that has numerous different actions. ...The aim of the present study was to examine the possible neuroprotective effect of PACAP in a rat model of diffuse axonal injury i …
Pituitary adenylate cyclase activating polypeptide (PACAP) is a widely distributed neuropeptide that has numerous different actions. …
Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Reglodi D, et al. Behav Brain Res. 2004 May 5;151(1-2):303-12. doi: 10.1016/j.bbr.2003.09.007. Behav Brain Res. 2004. PMID: 15084446
Pituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic neuropeptide, exerting different actions in the central and peripheral nervous systems. ...In the present study, we investigated the effects of PACAP in a rat model of Parkinson's disease. R …
Pituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic neuropeptide, exerting different actions in the central a …
195 results
Jump to page
Feedback